Medico Remedies Limited (NSE:MEDICO) — Market Cap & Net Worth
Market Cap & Net Worth: Medico Remedies Limited (MEDICO)
Medico Remedies Limited (NSE:MEDICO) has a market capitalization of $31.31 Million (Rs2.90 Billion) as of September 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #23717 globally and #1309 in its home market, demonstrating a -1.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medico Remedies Limited's stock price Rs34.89 by its total outstanding shares 82984000 (82.98 Million). Also see MEDICO total asset value for a full breakdown of the balance sheet.
Medico Remedies Limited Market Cap History: 2022 to 2026
Medico Remedies Limited's market capitalization history from 2022 to 2026. Data shows growth from $58.49 Million to $31.31 Million (8.84% CAGR). Also see Medico Remedies Limited cash conversion from operations for how efficiently the company converts equity into cash flow.
Medico Remedies Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medico Remedies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Medico Remedies Limited stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.02x
Medico Remedies Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.24x
Medico Remedies Limited's market cap is 0.24 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $58.49 Million | $1.21 Billion | $48.12 Million | 0.05x | 1.22x |
| 2023 | $75.21 Million | $1.40 Billion | $72.42 Million | 0.05x | 1.04x |
| 2024 | $49.31 Million | $1.45 Billion | $82.91 Million | 0.03x | 0.59x |
| 2025 | $45.41 Million | $1.51 Billion | $100.93 Million | 0.03x | 0.45x |
| 2026 | $31.31 Million | $2.06 Billion | $131.15 Million | 0.02x | 0.24x |
Competitor Companies of MEDICO by Market Capitalization
Companies near Medico Remedies Limited in the global market cap rankings as of September 19, 2026. Review tangible equity quality of Medico Remedies Limited to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Medico Remedies Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Medico Remedies Limited Historical Marketcap From 2022 to 2026
Between 2022 and today, Medico Remedies Limited's market cap moved from $58.49 Million to $ 31.31 Million, with a yearly change of 8.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs31.31 Million | -31.05% |
| 2025 | Rs45.41 Million | -7.92% |
| 2024 | Rs49.31 Million | -34.43% |
| 2023 | Rs75.21 Million | +28.59% |
| 2022 | Rs58.49 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Medico Remedies Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $31.31 Million USD |
| MoneyControl | $31.31 Million USD |
| MarketWatch | $31.31 Million USD |
| marketcap.company | $31.31 Million USD |
| Reuters | $31.31 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more